Urgent.News

What's breaking now, across thousands of outlets.

AI

Drug ads can influence AI treatment recommendations, study finds

As people increasingly turn to artificial intelligence (AI) for health information, a new study by researchers at the Icahn School of Medicine at Mount Sinai raises questions about what happens when commercial advertising appears alongside a clinical question. The findings were reported in the Nov. 11 online issue of The Lancet Digital Health.

Drug ads can influence AI treatment recommendations, study finds

We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.

Read the original at medicalxpress.com →

More in AI

Okta’s Real Opportunity Isn’t Its S&P 500 Spot. It’s AI Agents.

Okta's S&P 500 promotion is attracting attention, but its lasting opportunity depends on something else. Discover what could drive its next chapter and what might hold the stock back.

  • Okta's inclusion in S&P 500 may have short-lived impact.
  • Autonomous AI agents present significant growth opportunity.
  • Analysts note challenge of converting early deals into income.

More from Wednesday 11 November →